Osteoporosis

PubMed Free Full Text

Osteoporosis: parathyroid hormone

Canada

• Osteoporosis Canada
  • Clinical practice guidelines for the use of parathyroid hormone in the treatment of osteoporosis [2006]

Europe

• Calcified Tissue International
  • Effects of Teriparatide in Patients with Osteoporosis in Clinical Practice: 42-Month Results During and After Discontinuation of Treatment from the European Extended Forsteo® Observational Study (ExFOS) [2018]

International

• Bone Reports
  • The efficacy of teriparatide on lumbar spine bone mineral density, vertebral fracture incidence and pain in post-menopausal osteoporotic patients: A systematic review and meta-analysis [2020]

• Therapeutic Advances in Musculoskeletal Disease
  • Update on the safety and efficacy of teriparatide in the treatment of osteoporosis [2019]

Iran

• Iranian Journal of Pharmaceutical Research
  • Teriparatide in the Treatment of Severe Postmenopausal Osteoporosis: A Cost-Utility Analysis [2019]

Japan

• Clinical Interventions in Aging
  • Safety and effectiveness of daily teriparatide in a prospective observational study in patients with osteoporosis at high risk of fracture in Japan: final report [2016]

• Osteoporosis and Sarcopenia
  • Safety and efficacy in actual clinical practice of once-weekly subcutaneous teriparatide for osteoporosis patients with a high fracture risk [2019]

Middle East

• Journal of International Medical Research
  • Middle East experience from the Asia And Latin America Fracture Observational Study (ALAFOS): Baseline characteristics of postmenopausal women with osteoporosis using teriparatide [2020]

United States

• Cureus
  • Profile of Abaloparatide and Its Potential in the Treatment of Postmenopausal Osteoporosis [2017]

• Current Osteoporosis Reports
  • Parathyroid Hormone and Parathyroid Hormone-related Protein Analogs as Therapies for Osteoporosis [2013]

{Related topics}

• Topic
  • Osteoporosis: prevention, treatment